Clinical Trials in Integrative Therapies

Seminars in Oncology Nursing

Volumn 28, Issue 1, 2012, Pages 10-28

  Barton, Debra L ^a   Pachman, Deirdre R ^b  

^a MAYO CLINIC CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Clinical trials; Integrative therapies; Mind body therapies; Natural products

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; MEDICAL RESEARCH; METHODOLOGY; NEOPLASM; NURSING; ONCOLOGY NURSING;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COMPLEMENTARY THERAPIES; HUMANS; MIND-BODY THERAPIES; NEOPLASMS; ONCOLOGIC NURSING;

EID: 84856247667     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2011.11.003     Document Type: Article

References (126)

1. Barnes P.M., Bloom B., Nahin R.L. Complementary and alternative medicine use among adults and children: United States. Natl Health Stat Report 2007, 2008(18):1-23.
2. Schieman C., Rudmik L.R., Dixon E., et al. Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients. Can J Surg 2009, 52:422-426.
3. Bell R.M. A review of complementary and alternative medicine practices among cancer survivors. Clin J Oncol Nurs 2010, 14:365-370.
4. Boon H.S., Olatunde F., Zick S.M. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007, 7:4.
5. Mao J.J., Palmer C.S., Healy K.E., et al. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv 2011, 5:8-17.
6. Brauer J.A., El Sehamy A., Metz J.M., et al. Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites. J Altern Complement Med 2010, 16:183-186.
7. Merriam Webster Medical Dictionary. intelihealth, 2009. Available at: (accessed September 1, 2011). http://www.intelihealth.com/cgi-bin/dictionary.
8. Schelling F.A. Clinical trials: deliberations on their essence and value. J Eval Clin Pract 2004, 10:291-296.
9. Lancaster G.A., Dodd S., Williamson P.R. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004, 10:307-312.
10. Quella S.K., Loprinzi C.L., Barton D.L., et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol 2000, 18:1068-1074.
11. Barton D.L., Loprinzi C.L., Quella S.K., et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998, 16:495-500.
12. Kottschade L.A., Sloan J.A., Mazurczak M.A., et al. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer 2010, 19:1769-1777.
13. Pockaj B.A., Gallagher J.G., Loprinzi C.L., et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006, 24:2836-2841.
14. Ellison N., Loprinzi C.L., Kugler J., et al. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol 1997, 15:2974-2980.
15. Barton D.L., Atherton P.J., Bauer B.A., et al. The use of valeriana officinalis (valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study: NCCTG Trial, N01C5. J Support Oncol 2011, 9:24-31.
16. Ryan J.L., Heckler C.E., Roscoe J.A., et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 2011, [Epub ahead of print].
17. A randomized, double-blind placebo-controlled study of oral coenzyme Q10 to relieve self-reported cancer-treatment-related fatigue in newly diagnosed breast cancer patients. Lesser G., Case L., Stark N., et al. J Clin Oncol, 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2010;28(suppl):9006.
18. Guo Y, Palmer J, Forman A, et al. A randomized, double-blinded, placebo-controlled trial of oral alpha lipoic acid to prevent platinum-induced polyneuropathy. J Clin Oncol, 2011 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2011;29(suppl): 9010.
19. Williams M.S., Burk M., Loprinzi C.L., et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996, 36:345-349.
20. Fidler P., Loprinzi C.L., O'Fallon J.R., et al. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 1996, 77:522-525.
21. Pruthi S., Thompson S., Novotny P., et al. Pilot evaluation of flaxseed for the management of hot flashes. J Soc Integrat Oncol 2007, 5:106-112.
22. High KP, Case L, Siegel R, et al. A phase III randomized, double-blind, placebo controlled trial of North American (NA) ginseng (Panax quinquefolium) extract (CVT-E002) in patients with chronic lymphocytic leukemia: effect on respiratory infection and antibiotic use. J Clin Oncol, 2010 ASCO AnnualMeeting Proceedings (Post-Meeting Edition). 2010; 28(suppl):6578.
23. Barton D.L., Soori G.S., Bauer B.A., et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 2010, 18:179-187.
24. Greven K, Case LD, Nycum R, et al. Does L-arginine/Korean ginseng/ginko biloba/damiana-based supplementation improve the sexual function and quality of life od female cancer survivors: A randomized trial. J Clin Oncol, 2011 ASCO AnnualMeeting Proceedings (Post-Meeting Edition). 2011; 29(suppl):9016.
25. Cruciani R.A., Dvorkin E., Homel P., et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006, 32:551-559.
26. Cruciani R, Zhang J, Manola J, et al. Phase III randomized, placebo-controlled trial of L-carnitine supplementation for fatigue in patients with cancer. J Clin Oncol, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2009;27(suppl):e20532.
27. Grothey A., Nikcevich D.A., Sloan J.A., et al. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol 2011, 29:421-427.
28. Kozelsky T.F., Meyers G.E., Sloan J.A., et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol 2003, 21:1669-1674.
29. Halyard M.Y., Jatoi A., Sloan J.A., et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007, 67:1318-1322.
30. Mustian K, Palesh O, Sprod L, et al. Effect of YOCAS yoga on sleep, fatigue, and quality of life: A URCC CCOP randomized, controlled clinical trial among 410 cancer survivors. J Clin Oncol, 2011 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2011;29(suppl):9034.
31. Manusirivithaya S., Sripramote M., Tangjitgamol S., et al. Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin. Int J Gynecol Cancer 2004, 14:1063-1069.
32. Zick S.M., Ruffin M.T., Lee J., et al. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer 2009, 17:563-572.
33. Levine M.E., Gillis M.G., Koch S.Y., et al. Protein and ginger for the treatment of chemotherapy-induced delayed nausea. JAltern Complement Med 2008, 14:545-551.
34. Kim J.H., Park C.Y., Lee S.J. Effects of sun ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial. J Clin Pharm Ther 2006, 31:331-334.
35. Younus J., Collins A., Wang X., et al. A double blind placebo controlled pilot trial study to evaluate the effect of ginseng on fatigue and quality of life in adult chemo-naive cancer patients (abstr 2947). Proc Am Soc Clin Oncol 2003, 22:2947.
36. Burns C.P., Halabi S., Clamon G.H., et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res 1999, 5:3942-3947.
37. Cerchietti L.C., Navigante A.H., Castro M.A. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 2007, 59:14-20.
38. Wigmore S.J., Ross J.A., Falconer J.S., et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996, 12:S27-S30.
39. Barber M.D., Fearon K.C., Tisdale M.J., et al. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001, 40:118-124.
40. Wigmore S.J., Barber M.D., Ross J.A., et al. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000, 36:177-184.
41. Burns C.P., Halabi S., Clamon G., et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 2004, 101:370-378.
42. Persson C., Glimelius B., Ronnelid J., et al. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition 2005, 21:170-178.
43. Bruera E., Strasser F., Palmer J.L., et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 2003, 21:129-134.
44. Jatoi A., Rowland K., Loprinzi C.L., et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004, 22:2469-2476.
45. Fearon K.C., Von Meyenfeldt M.F., Moses A.G., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003, 52:1479-1486.
46. van Breemen R.B., Liang W., Banuvar S., et al. Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh. Clin Pharmacol Ther 2010, 87:219-225.
47. Pockaj B.A., Loprinzi C.L., Sloan J.A., et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004, 22:515-521.
48. Rostock M., Fischer J., Mumm A., et al. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study. Gynecol Endocrinol 2011, 27:844-848.
49. Jacobson J.S., Troxel A.B., Evans J., et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001, 19:2739-2745.
50. Bardy J., Molassiotis A., Ryder W.D., et al. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Br J Oral Maxillofac Surg 2011, [Epub ahead of print].
51. Khanal B., Baliga M., Uppal N. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. Int J Oral Maxillofac Surg 2010, 39:1181-1185.
52. Rashad U.M., Al-Gezawy S.M., El-Gezawy E., et al. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol Otol 2009, 123:223-228.
53. Motallebnejad M., Akram S., Moghadamnia A., et al. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. J Contemp Dent Pract 2008, 9:40-47.
54. Biswal B.M., Zakaria A., Ahmad N.M. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer 2003, 11:242-248.
55. Maddocks-Jennings W., Wilkinson J.M., Cavanagh H.M., et al. Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study. Eur J Oncol Nurs 2009, 13:87-93.
56. Moolenaar M., Poorter R.L., van der Toorn P.P., et al. The effect of honey compared to conventional treatment on healing of radiotherapy-induced skin toxicity in breast cancer patients. Acta Oncol 2006, 45:623-624.
57. Shoma A., Eldars W., Noman N., et al. Pentoxifylline and local honey for radiation-induced burn following breast conservative surgery. Curr Clin Pharmacol 2010, 5:251-256.
58. Muscaritoli M., Micozzi A., Conversano L., et al. Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity. Eur J Cancer 1997, 33:319-320.
59. Daniele B., Perrone F., Gallo C., et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut 2001, 48:28-33.
60. Bozzetti F., Biganzoli L., Gavazzi C., et al. Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study. Nutrition 1997, 13:748-751.
61. Canovas G., Leon-Sanz M., Gomez P., et al. Oral glutamine supplements in autologous hematopoietic transplant: impact on gastrointestinal toxicity and plasma protein levels. Haematologica 2000, 85:1229-1230.
62. Li Y., Yu Z., Liu F., et al. Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial. Tumori 2006, 92:396-401.
63. Li Y., Ping X., Yu B. e al. Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy-a randomized crossover study. Aliment Pharmacol Ther 2009, 30:452-458.
64. Pytlik R., Benes P., Patorkova M., et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant 2002, 30:953-961.
65. Schloerb P.R., Skikne B.S. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr 1999, 23:117-122.
66. Sornsuvit C., Komindr S., Chuncharunee S., et al. Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients. J Int Med Res 2008, 36:1383-1391.
67. Yoshida S., Matsui M., Shirouzu Y., et al. Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 1998, 227:485-491.
68. van Zaanen H.C., van der Lelie H., Timmer J.G., et al. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 1994, 74:2879-2884.
69. Skubitz K.M., Anderson P.M. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med 1996, 127:223-228.
70. Piccirillo N., De Matteis S., Laurenti L., et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 2003, 88:192-200.
71. Cerchietti L.C., Navigante A.H., Lutteral M.A., et al. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006, 65:1330-1337.
72. Choi K., Lee S.S., Oh S.J., et al. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr 2007, 26:57-62.
73. Huang E.Y., Leung S.W., Wang C.J., et al. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 2000, 46:535-539.
74. Anderson P.M., Schroeder G., Skubitz K.M. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 1998, 83:1433-1439.
75. Jebb S.A., Osborne R.J., Maughan T.S., et al. 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. Br J Cancer 1994, 70:732-735.
76. Decker-Baumann C., Buhl K., Frohmuller S., et al. Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer. Eur J Cancer 1999, 35:202-207.
77. Peterson D.E., Jones J.B., Petit R.G. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer 2007, 109:322-331.
78. Okuno S.H., Woodhouse C.O., Loprinzi C.L., et al. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol 1999, 22:258-261.
79. Stubblefield M.D., Vahdat L.T., Balmaceda C.M., et al. Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study. Clin Oncol (R Coll Radiol) 2005, 17:271-276.
80. Vahdat L., Papadopoulos K., Lange D., et al. Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res 2001, 7:1192-1197.
81. Wang W.S., Lin J.K., Lin T.C., et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 2007, 12:312-319.
82. Loven D., Levavi H., Sabach G., et al. Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel. Eur J Cancer Care 2009, 18:78-83.
83. Jacobson S.D., Loprinzi C.L., Sloan J.A., et al. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol 2003, 1:274-278.
84. Strasser F., Demmer R., Bohme C., et al. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. Oncologist 2008, 13:337-346.
85. May P.E., Barber A., D'Olimpio J.T., et al. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 2002, 183:471-479.
86. Berk L., James J., Schwartz A., et al. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer 2008, 16:1179-1188.
87. Barton D. Ginseng. Oncol Nurse Ed 2011, 25:42-45.
88. Harkey M.R., Henderson G.L., Gershwin M.E., et al. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001, 73:1101-1106.
89. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999, 58:1685-1693.
90. Sloan J.A., Loprinzi C.L., Novotny P.J., et al. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001, 19:4280-4290.
91. Suvanto-Luukkonen E., Koivunen R., Sundstrom H., et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005, 12:18-26.
92. Schwertner H.A., Rios D.C., Pascoe J.E. Variation in concentration and labeling of ginger root dietary supplements. Obstet Gynecol 2006, 107:1337-1343.
93. Anand P., Kunnumakkara A.B., Newman R.A., et al. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4:807-818.
94. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-7.
95. Sharma R.A., Gescher A.J., Steward W.P. Curcumin: the story so far. Eur J Cancer 2005, 41:1955-1968.
96. Branstrom R., Kvillemo P., Brandberg Y., et al. Self-report mindfulness as a mediator of psychological well-being in a stress reduction intervention for cancer patients-a randomized study. Ann Behav Med 2010, 39:151-161.
97. Foley E., Baillie A., Huxter M., et al. Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: a randomized controlled trial. J Consult Clin Psychol 2010, 78:72-79.
98. Lengacher C.A., Johnson-Mallard V., Post-White J., et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 2009, 18:1261-1272.
99. Monti D.A., Peterson C., Kunkel E.J., et al. A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psychooncology 2006, 15:363-373.
100. Speca M., Carlson L.E., Goodey E., et al. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000, 62:613-622.
101. Shapiro S.L., Bootzin R.R., Figueredo A.J., et al. The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J Psychosom Res 2003, 54:85-91.
102. Garland S.N., Carlson L.E., Cook S., et al. A non-randomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating post-traumatic growth and spirituality in cancer outpatients. Support Care Cancer 2007, 15:949-961.
103. Garland S.N., Carlson L.E., Antle M.C., et al. I-CAN SLEEP: Rationale and design of a non-inferiority RCT of mindfulness-based stress reduction and cognitive behavioral therapy for the treatment of insomnia in cancer survivors. Contemp Clin Trials 2011, 32:747-754.
104. Carlson L.E., Speca M., Patel K.D., et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003, 65:571-581.
105. Carlson L.E., Speca M., Patel K.D., et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004, 29:448-474.
106. Carlson L.E., Speca M., Faris P., et al. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 2007, 21:1038-1049.
107. Carlson L.E., Garland S.N. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 2005, 12:278-285.
108. Bauer-Wu S, Carmody J, Cooley M, et al. A randomized controlled trial of mindfulness training for cancer patients undergoing stem cell transplant. Presented at the Society of Behavioral Medicine 32nd Annual Meeting and Scientific Sessions. Washington, DC; 2011.
109. Littman A.J., Bertram L.C., Ceballos R., et al. Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer 2011, [Epub ahead of print].
110. Banasik J., Williams H., Haberman M., et al. Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors. J Am Acad Nurse Pract 2011, 23:135-142.
111. Chandwani K.D., Thornton B., Perkins G.H., et al. Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancer. J Soc Integr Oncol 2010, 8:43-55.
112. Carson J.W., Carson K.M., Porter L.S., et al. Yoga of awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support Care Cancer 2009, 17:1301-1309.
113. Danhauer S.C., Mihalko S.L., Russell G.B., et al. Restorative yoga for women with breast cancer: findings from a randomized pilot study. Psychooncology 2009, 18:360-368.
114. Moadel A.B., Shah C., Wylie-Rosett J., et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. J Clin Oncol 2007, 25:4387-4395.
115. Culos-Reed S.N., Carlson L.E., Daroux L.M., et al. A pilot study of yoga for breast cancer survivors: physical and psychological benefits. Psychooncology 2006, 15:891-897.
116. Cohen L., Warneke C., Fouladi R.T., et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004, 100:2253-2260.
117. Rao M.R., Raghuram N., Nagendra H.R., et al. Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial. Complement Ther Med 2009, 17:1-8.
118. Vadiraja S.H., Rao M.R., Nagendra R.H., et al. Effects of yoga on symptom management in breast cancer patients: a randomized controlled trial. Int J Yoga 2009, 2:73-79.
119. Raghavendra R.M., Nagarathna R., Nagendra H.R., et al. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur J Cancer Care (Engl) 2007, 16:462-474.
120. Banerjee B., Vadiraj H.S., Ram A., et al. Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiotherapy. Integr Cancer Ther 2007, 6:242-250.
121. Cohen L, Chandwani K, Raghuram N, et al. Effect of yoga on QOL, cortisol rhythym, and HRV for women with breast cancer undergoing radiotherapy. J Clin Oncol, 2011 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2011;29(suppl):9009.
122. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness 1990, Bantam Dell, New York, NY.
123. Smith K.B., Pukall C.F. An evidence-based review of yoga as a complementary intervention for patients with cancer. Psychooncology 2009, 18:465-475.
124. Post-White J., Kinney M.E., Savik K., et al. Therapeutic massage and healing touch improve symptoms in cancer. Integrat Cancer Ther 2003, 2:332-344.
125. Ahles T.A., Tope D.M., Pinkson B., et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage 1999, 18:157-163.
126. Beck C., McSweeney J.C., Richards K.C., et al. Challenges in tailored intervention research. Nurs Outlook 2010, 58:104-110.